Avient vs DuPont de Nemours
AVNT and DD side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVNT and DD compare
DuPont de Nemours is the larger company, worth 5.0 times as much as Avient ($21.2B against $4.2B).
On earnings, Avient is cheaper: it trades at 23.7× trailing earnings, against 349× for DuPont de Nemours.
Avient grew revenue faster over the last twelve months (5.2% versus 3.3% for DuPont de Nemours).
Avient keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with 0.79% at DuPont de Nemours.
Both pay dividends: Avient yields 2.4% and DuPont de Nemours 1.5%.
Avient scores higher on the StockData Score (13 against 8 for DuPont de Nemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVNT | DD |
|---|---|---|
| Size and price | ||
| Market cap | $4.2B | $21.2B |
| Share price | $46.23 | $156.88 |
| Change, 1 year | 56.0% | 31.4% |
| Change, 5 years | −23.0% | −34.6% |
| Beta (5Y) | 1.34 | 1.14 |
| Employees | 9,000 | 15K |
| StockData Score | ||
| Total score | 13 (better) | 8 |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 2 (better) | 0 |
| Health score | 2 | 4 (better) |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 23.7× (better) | 349× |
| P/S | 1.2× (better) | 3.0× |
| P/B | 1.7× | 1.5× (better) |
| EV/EBITDA | 10.8× (better) | 24.8× |
| P/FCF | 17.7× (better) | 30.2× |
| FCF yield | 5.6% (better) | 3.3% |
| Fair value | $54.10 | $98.38 |
| Margin of safety | 14.5% (better) | −59.5% |
| Growth | ||
| Revenue growth (TTM) | 5.2% (better) | 3.3% |
| Revenue growth, 5Y average | 8.0% (better) | −9.3% |
| Net income growth (TTM) | 59.0% | – |
| EPS growth (TTM) | 57.3% | – |
| EPS growth, 5Y average | −9.3% | – |
| Profitability | ||
| Gross margin | 31.7% | 35.1% (better) |
| Operating margin | 9.7% | – |
| Net margin | 5.3% (better) | 0.79% |
| FCF margin | 7.0% | 10.0% (better) |
| Return on equity | 7.5% (better) | 0.30% |
| Return on invested capital | 6.4% | – |
| Financial health | ||
| Debt / equity | 0.74 | 0.23 (better) |
| Net debt / EBITDA | 2.65 | 1.52 (better) |
| Current ratio | 1.71 | 2.43 (better) |
| Altman Z-score | 1.62 (better) | 0.65 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% (better) | 1.5% |
| Payout ratio | 55.7% | 758% |
| Years of dividend growth | 15 (better) | 0 |
| Dividend growth, 5Y average | 5.8% (better) | 3.6% |
| Buyback yield | – | −0.64% |
| Shareholder yield | 2.4% (better) | 0.89% |
| Ownership | ||
| Held by institutions | 105% | 73.7% |
| Held by insiders | 0.83% | 0.75% |
| Insider net buying, 12 months | – | −$14.2M |
| Short interest, % of float | 4.7% | 2.9% |
Go deeper
- AVNT stock overview
- AVNT income statement
- AVNT valuation and score
- DD stock overview
- DD income statement
- DD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.